Cryopreservation equipment refers to the equipment used for cryopreservation or cryostorage of biological materials like stem cells, sperm, eggs, embryos, oocytes, blood, and blood vessels at ultra-low temperatures, generally in liquid nitrogen. Cryopreservation equipment like cryopreservation tanks, cryopreservation vials, cryopreservation freezers, are used to store biological samples for extended period of time without damage by slow freezing at very low temperatures. The global cryopreservation equipment market largely caters to industries like biotechnology, pharmaceuticals, healthcare, stem cell research, animal breeder conservation programs, and others.

The global cryopreservation equipment market is estimated to be valued at US$ 9059.28 Mn in 2023 and is expected to exhibit a CAGR of 4.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity: Rising stem cell research is expected to drive the growth of cryopreservation equipment market during the forecast period. Stem cell research offers breakthrough opportunities for diseases like cancer, diabetes, spinal cord injuries, and more. Cryopreservation plays a critical role in stem cell research as it helps in long term storage of stem cells. Thus, with increasing number of stem cell research activities globally, the demand for cryopreservation equipment will also increase significantly. This presents a major market opportunity for manufacturers of cryopreservation equipment. With increased collaborations between biotech companies, research institutes and equipment manufacturers, the stem cell research segment can become the main driver of cryopreservation equipment market during the forecast period.

Porter’s Analysis

Threat of new entrants: Low capital requirements and established suppliers lower the threat of new entrants in this market. The industry players enjoy advantages of economies of scale and access to sophisticated technologies.

Bargaining power of buyers: The bargaining power of buyers is moderate. The availability of substitute products provides options to buyers. However, specialized medical skills required for these cryopreservation systems increase switching costs.

Bargaining power of suppliers: A few large companies dominate the supply of critical components like coolants and hardware, giving them significant influence over prices. Suppliers can threaten forward integration also.

Threat of new substitutes: Products from tissue engineering offer an alternative, though they may not perfectly replace cryopreservation in all applications. Overall, the threat of substitutes is moderate to high.

Competitive rivalry: The market faces high competition due to large number of global and regional players. Companies compete on the basis of technologies, quality, services, and pricing.

SWOT Analysis
Strength: Cryopreservation equipment have widespread applications in assisted reproduction, stem cell banking, and biological sample preservation. Advances in cooling technologies augment efficiency.
Weakness: High costs of equipment, maintenance and consumables limit their access. Stringent regulatory approvals and standards increase compliance burdens.
Opportunity: Growing stem cell therapy and assisted reproduction verticals in developing regions present lucrative expansion avenues. Emergence of standalone sperm and egg banks offers opportunities.
Threats: Entry of local players manufacturing low-cost equipment poses pricing pressures. Constraints on global supply chains due to COVID-19 pandemic threaten timely delivery of products and services.

Key Takeaways

The global Cryopreservation Equipment Market Analysis is expected to witness high during 2023-2030.The market was valued at US$ 9059.28 Mn in 2023 and is projected to reach US$ 16,234.17 Mn by 2030 expanding at a CAGR of 4.9%. Asia Pacific region dominates the market with over 35% share in 2023 due to increasing fertility tourism and rising medical tourism in countries like India and China.

Regional analysis: Asia Pacific region is projected to witness the fastest growth during the forecast period owing to increasing healthcare awareness, rising disposable incomes, expansion of healthcare infrastructure especially in India and China along with increasing acceptance of advanced medical solutions. The region held around 35% share of the global cryopreservation equipment market in 2023.

Key players: Key players operating in the cryopreservation equipment market are Ferring B.V., Bayer AG, Braintree, Bausch Health Companies Inc., and Norgine B.V. Ferring B.V. is a leader in biopharmaceuticals and wellness products focusing on reproductive medicine and women's health. It holds around 15% market share in 2023 globally.

Get more insights on this topic: https://www.trendingwebwire.com/cryopreservation-equipment-market-demand-forecast/